Satsuma Pharmaceuticals, Inc. Lease, Cost
Satsuma Pharmaceuticals, Inc. reported Lease, Cost of $78.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2023-05-11
- Satsuma Pharmaceuticals, Inc. lease, cost for the quarter ending 2023-03-31 was $78.00K, a 8.33% increase year-over-year.
- Satsuma Pharmaceuticals, Inc. lease, cost for the quarter ending 2022-12-31 was $85.00K.
- Satsuma Pharmaceuticals, Inc. lease, cost for the quarter ending 2022-09-30 was $82.00K.
- Satsuma Pharmaceuticals, Inc. lease, cost for the quarter ending 2022-06-30 was $82.00K.
- Satsuma Pharmaceuticals, Inc. lease, cost for fiscal 2022 was $321.00K.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-03-31 | $78.00K 10-Q · filed 2023-05-11 | $163.00K derived: sum of 2 quarters · filed 2023-05-11 | $245.00K derived: sum of 3 quarters · filed 2023-05-11 | $327.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $167.00K derived: sum of 2 quarters · filed 2023-03-28 | $249.00K derived: sum of 3 quarters · filed 2023-03-28 | $321.00K 10-K · filed 2023-03-28 |
| 2022-09-30 | $82.00K 10-Q · filed 2022-11-03 | $164.00K derived: sum of 2 quarters · filed 2022-11-03 | $236.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $82.00K 10-Q · filed 2022-08-09 | $154.00K 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | $72.00K 10-Q · filed 2023-05-11 |